SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Creamer P, Hochberg MC (1997) Osteoarthritis. Lancet 350, 5038.
  • 2
    O'Dell JR, Paulsen G, Haire CE (1999) Treatment of early seropositive rheumatoid arthritis with minocycline: four-year follows up of a double blind, placebo-controlled trial. Arth Rheum 42, 16915.
  • 3
    Marshall SE (2004) Behçet's disease. Best Prac Res Clin Rheum 18, 291311.
  • 4
    Rajesh N, Mukundan G, Mandar NA (1999) Novel mechanism of action of chemically modified tetracycline’: inhibition of COX-2-Med prostaglandin E2 production. J Immunol 163, 345967.
  • 5
    Menninger JR, Otto DP (1982) Erythromycin, carbomycin, and spiramycin inhibit protein synthesis by stimulating the dissociation of peptidyl-tRNA from ribosomes. Antimicrob Agents Chemother 21, 8118.
  • 6
    Kudoh S, Azuma A, Yamamoto M, Izumi T, Ando M (1998) Improvement of Survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin. Am J Respir Crit Care Med 157, 182932.
  • 7
    Culic O, Erakovic V, Parnham MJ (2001) Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 429, 20929.
  • 8
    Takeshita K, Yamagishi I, Harada M, Otomo S, Nakagawa T, Mizushima Y (1989) Immunological and anti-inflammatory effects of clarithromycin: Inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp Clin Res 15, 52733.
  • 9
    Hand WL, Hand DL, King-Thompson NL (1990) Antibiotic inhibition of the respiratory burst response in human polymorphonuclear leukocytes. Antimicrob Agents Chem 34, 86370.
  • 10
    Mikasa K, Kita E, Sawaki M, et al . (1992) The anti-inflammatory effect of erythromycin in zymosan-induced peritonitis of mice. J Antimicrob Chemother 30, 33948.
  • 11
    Konno S, Asano K, Kurokawa M, Ikeda K, Okamoto K, Adachi M (1994) Antiasthmatic activity of a macrolide antibiotic, roxithromycin: Analysis of possible mechanisms in vitro and in vivo. Int Arch Allergy Immunol 105, 30816.
  • 12
    Laufen H, Wildfeuer A, Räder K (1985) Uptake of antimicrobial agents by human polymorphonuclear leucocytes. Arzneimittelforschung 35, 10979.
  • 13
    Labro MT, Abdelghaffar H (2001) Immunomodulation by macrolide antibiotics. J Chemother 13, 38.
  • 14
    Altman R, Asch E, Bloch G, et al . (1986) Development of criteria for the classification and reporting of osteoarthritis. Arthritis Rheum 29, 103949.
  • 15
    Nijs J, Van Geel C, Van der auwera C, Van de Velde B (2006) Diagnostic value of five clinical tests in patellofemoral pain syndrome. Man Ther 11, 6977.
  • 16
    Bellamy N, Buchanan WW, Goldsmith CH, Campblel J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 15, 183340.
  • 17
    Gajdosik RL, Bohannon RW (1987) Clinical measurement of range of motion; Review of goniometry emphasizing reliability and validity. Phys Therap 67, 186772.
  • 18
    Eadie WT, Drijard D, James FE, Roos M, Sadoulet B (1971) Statistical Methods in Experimental Physics, pp. 26971. North-Holland, Amsterdam.
  • 19
    Felson DT, McAlindon TE, Anderson JJ, et al . (1997) Defining radiographic osteoarthritis for the whole knee. Osteoarth Cartil 5, 24150.
  • 20
    Brandt KD, Doberty M, Lobmander S, et al . (1998) Osteoarthritis. Oxford University Press, New York.
  • 21
    Smith MD, Triantafillou S, Parker A, Youssef PP, Coleman M (1997) Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 24, 36571.
  • 22
    Bjordal JM, Ljunggren AE, Klovning A (2004) Non-steroidal anti-inflammatory drugs, including coxibs, in osteoarthritic knee pain: a meta-analysis of randomized placebo-controlled trials. BMJ 329, 131720.
  • 23
    British Medical Association, Royal Pharmaceutical Society of Great Britain (2004) British National Formulary. BMA, RPS, London. (No 48).
  • 24
    Brandt KD, Bradley JD (2001) Should the initial drug used to treat osteoarthritis pain be a nonsteroidal anti-inflammatory drug? J Rheumatol 28, 46773.
  • 25
    Gossec L, Dougados M (2004) Intra-articular treatments in osteoarthritis: from the symptomatic to the structure modifying. Ann Rheum Dis 63, 47882.
  • 26
    Charalambous Cp, Tryfonidis M, Sadiq S (2003) Septic arthritis following intra-articular steroid injection of the knee. Clin Rheumtol 22, 38690.
  • 27
    Reuven M, Idit L, Rafael L (2005) Evaluation of the pituitary-adrenal axis function following single intraarticular injection of methylprednisolone. Arthritis Rheum 52, 9248.
  • 28
    Reid DM, Patel S, Reid IW (1983) Hypothalamic-pituitary-adrenal (HPA) axis function in patients receiving long-term intra-articular corticosteroids. Clinic Rheumatol 2, 15961.
  • 29
    Emkey RD, Lindsay R, Lyssy J, Weisberg J, Dempster D, Shen V (1996) The systemic effect of intra-articular administration of corticosteroid on markers of bone formation and bone resorption in patients with rheumatoid arthritis. Arthritis Rheum 39, 27782.
  • 30
    Bryskier A, Agouridas C, Chantot JF (1994) New medical targets for macrolides. Exp Opin Invest Drugs 3, 40510.
  • 31
    Zhao DM, Xue HH, Chida K, et al . (2000) Effect of erythromycin on ATP-induced intracellular calcium response in A549 cells. Am J Physiol Lung Cell Mol Physiol 278, 72636.
  • 32
    Idesaki M, Okazaki H, Takizawa H (2001) Effect of 14-membered ring macrolide on transcription factors in human bronchial epithelial cells. Jpn J Antibiotics 54, 435.
  • 33
    Lechapt-Zalcman E, Coste A, Pia d’Ortho M, et al . (2001) Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol 193, 23341.
  • 34
    Cawston T (1998) Matrix metalloproteinases and TIMPs: properties and implications for the rheumatic diseases. Mol Med Today 4, 1307.
  • 35
    Kadota J, Matsubara Y, Ishimatsu Y, et al . (1996) Significance of IL-1 and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse parabronchiolitis (DPB). Clin Exp Immunol 103, 4616.
  • 36
    Lazaar AL, Amrani Y, Hsu J, et al . (1998) CD40-mediated signal transduction in human airway smooth muscle. J Immunol 161, 31207.
  • 37
    Weiping R, Xiao HL, Ben DC, Wooley PH (2003) Erythromycin inhibits wear debris-induced osteoclastogenesis by modulation of murine macrophage NF-B activity. J Orthop Res 22, 219.
  • 38
    Ianaro A, Ialenti A, Maffia P, et al . (2000) Anti-Inflammatory Activity of Macrolide Antibiotics. Pharma Exp Therap 292, 15663.
  • 39
    Lotz M (1999) The role of nitric oxide in articular cartilage damage. Rheum Dis Clin North Am 25, 26982.
  • 40
    Tamaoki J (2004) The effects of macrolides on inflammatory cells. Chest 125, 41S51S.
  • 41
    Marcus JS (2004) Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemoth 54, 218.
  • 42
    Lehmann R, Brzosko M, Kopsa P, et al . (2005) Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib. Curr Med Res Opin 21, 51726.